AbbVie says bar for ‘sham litigation’ is too low
03-06-2021
FTC’s $448m AbbVie win overturned
02-10-2020
AbbVie and Besins to pay FTC $448m in sham litigation case
02-07-2018
Mark Van Scyoc / Shutterstock.com
The US Federal Trade Commission and AbbVie both want a federal appeals court to rehear a lawsuit accusing the drug company of quashing competition through sham patent litigation.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Third Circuit, FTC, AbbVie, Perrigo, Besins, antitrust, sham litigation, patent
